Publications

5891 Results

American Society of Clinical Oncology executive summary ofthe clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer [PMID 21343561]

Authors
CH Van Posnak;S Temin;NA Janian;WE Barlow;JS Bierman;LD Bosserman;C Geoghegan;BE Hillner;RL Theriault;DS Zuckerman;JH Von Roenn
Journal / Conference
Journal of Clinical Oncology 29(9):1221-1227
Year
2011
Research Committee(s)
Breast

Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group [PMID20878269]

Authors
RD Rao;M Cobleigh;R Gray;ML Graham;L Norton;S Martino;GT Budd;JN Ingle;WC Wood
Journal / Conference
Medical Oncology 28 Suppl 1:S39-47;
Year
2011
Research Committee(s)
Breast
Study Number(s)
SWOG-9514 (EB193)

Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial[PMID21300930; PMC3083866]

Authors
PA Ganz;SR Land;CE Geyer;RS Cecchini;JP Costantino;ER Pajon;L Fehrenbacher;JA Atkins;JA Polikoff;VG Vogel;JK Erban;RB Livingston;EA Perez;EP Mamounas;N Wolmark;SM Swain
Journal / Conference
Journal of Clinical Oncology 29(9):1110-1116
Year
2011
Research Committee(s)
Breast

Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial. PMID21335507; PMC3070045

Authors
A Kristal;C Till;E Platz;X Song;I King;M Neuhouser;C Ambrosone;IM Thompson
Journal / Conference
Cancer Epidemiology Biomarkers Prevention 20(4):638-646
Year
2011
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Finasteride reduces the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial

Authors
JK Parsons;J Schenk;K Arnold;K Messer;C Till;IM Thompson;A Kristal
Journal / Conference
AUA Annual Meeting, accepted, oral, late-breaking
Year
2011
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

SWOG S0215: A phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast [PMID21826527;PMC3513946]

Authors
R Livingston;W Barlow;J Kash;K Albain;J Gralow;D Lew;L Flaherty;ME Royce;GN Hortobagyi
Journal / Conference
Breast Cancer Research and Treatment 130(1):123-131;
Year
2011
Research Committee(s)
Breast
Study Number(s)
S0215

Measuring the performance of markers for guiding treatment decisions [PMID21320940; PMC3085402]

Authors
H Janes;J Pepe;W Barlow
Journal / Conference
Annals of Internal Medicine 154(4):253-259, 2011
Year
2011
Research Committee(s)
Multiple sites

C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the North Central Cancer Treatment Group N9831 adjuvant trastuzumab trial [PMID21245420; PMC3056653]

Authors
EA Perez;RB Jenkins;AC Dueck;AE Wiktor;PP Bedroske;SK Anderson;RP Kettering;WR Sukow;K Kanehira;B Chen;XJ Geiger;CA Andorfer;AE McCullough;N Davidson;S Martino;GW Sledge;PA Kaufman;LA Kutteh;J Gralow;LN Harris;JN Ingle;WL Lingle;MM Reinholz
Journal / Conference
Journal of Clinical Oncology 29(6):651-659
Year
2011
Research Committee(s)
Breast
Study Number(s)
N9831

High-dose chemotherapy with autologous stem cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials [PMID21768471]

Authors
DA Berry;NT Ueno;MM Johnson;X Lei;J Caputo;S Rodenhuis;W Peters;RC Leonard;WE Barlow;M Tallman;J Bergh;NA Nitz;AM Gianni;RL Basser;A Zander;RC Coombes;H Roche;Y Tokuda;E de Vries;G Hortobagyi;JP Crown;P Pedrazzoli;M Bregni;T Demirer
Journal / Conference
Journal of Clinical Oncology 29(24):3214-3223;
Year
2011
Research Committee(s)
Breast
Study Number(s)
S9623

Influence of residual normal metaphases in acute myeloid leukemia patients with monosomal karyotype [PMID21330329; PMC3069244]

Authors
B Xie;M Othus;B Medeiros;M Fang;F Appelbaum;E Estey
Journal / Conference
Haematologica 96(4):631-632
Year
2011
Research Committee(s)
Leukemia
Study Number(s)
S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9126, SWOG-9333, SWOG-9500, S9617, S9918